Long-term effect of intravenous calcitriol on the treatment of severe hyperparathyroidism, parathyroid gland mass and bone mineral density in haemodialysis patients

American Journal of Nephrology

Volumn 17, Issue 2, 1997, Pages 118-123

  Huraib, Sameer ^a   Abu Aisha, Nassau ^a   Abed, Jamal ^a   Waked, Jamal Al ^a   Desoukih, Mahmoud Al ^a   Menton, Nawaz ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Haemodialysis; Intravenous calcitriol; Parathyroid gland mass

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEMUR NECK; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SPINE;

EID: 0030898974     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169084     Document Type: Article

References (33)

1. Coburn JW, Statopolsky K: Vit D, PTH and renal osteodystrophy: in Brenner BM. et al (eds): The Kidney. Philadelphia. Saunders. 1986, chap 39. p 1657/Coburn JW: Renal osteodystrophy. Kidney Int 1980; 17:677-693.
2. Cobum JW: Use of oral and parenteral calci-triol in the treatment of renal osteodystrophy. Kidney Int 1990;38(suppl 29):554-561.
3. 2 D levels in renal disease. Kidney Int 1983:24:104.
4. Madsen S, Olgaard K: Long-term trial of 1-alpha-hydroxycholccalciferol in adults with chronic renal failure. Eur J Clin Pharmacol 1978:13:401-408.
5. Bcrl T, Bems AS, HufTer WE, Hammill K, Al Frey AC, Amaud ED, Shrier RW: 1,25-Dihy-droxy cholccalciferol effects in chronic dialysis. Ann Intern Med 1978;88:774-780.
6. Brumbaugh P, Hughes M, Haussler M: Cytoplasmic and nuclear binding components for I -alpha-25-dihydroxy vitamin Dj in chick parathyroid glands. Proc Natl Acad Sci USA 1975; 72:4871-4875.
7. Silver J, Russel J, Sherwood L: Regulation by vitamin D metabolites of messenger ribo nucleic acid for preparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985:82:4270-4273.
8. 1.25Dihydroxy vitamin Dj suppress parathyroid secretion from bovine parathyroid cells in tissue culture. Endocrinology 1985; 117: 2114-2119.
9. 2 of transcription of the parathyroid hormone gene. Endocrinology 1986,119:2114-2119.
10. 1.25dihydroxy cholccalciferol in uremic patients. J Clin Invest 1984: 74:2136-2143.
11. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Shcrrard DJ: Intravenous caicitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989:321: 274-279.
12. Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA: Prospective trial of pulse oral versus intravenous caicitriol treatment of hyperparathyroidism in ESRD. Kidney Int 1994:45:1710-1721.
13. Cannella G, Bonucci E, Rolla D, Ballante P, Mariero E, De Grandi R, Augeri C, Claudiani F. Di MaioG: Evidence of healing of secondary hyperparathyroidism in chronically hemodia-lyzcd uremic patients treated with long-term intravenous caicitriol. Kidney Int 1994:46: 1124-1132.
14. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Scgrc GV, Salusky IB: Development of a dynamic bone in patients with secondary hyperparathyroidism after intermittent caicitriol therapy. Kidney Int 1994:46:1160-1166.
15. Rodriguez M, Fclscnfeld A, Williams C, Pederson J, Llach F: The effect of long term intravenous caicitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 1991;2:1014-1020.
16. Ruedin P, Rizzoli R, Slosman D, Leski M, Bonjour J: Effect of oral caicitriol on bone mineral density in patients with end-stage renal failure. Kidney Int 1994:45:245-252.
17. Fischer E, Harris D: Comparison of intermittent oral and intravenous caicitriol in haemodi-alysis patients with secondary hyperparathyroidism. Clin Nephrol 1993;40:216-220.
18. Fukagawa M, Okazaki R, Takano K, Kanamc SY, Ogata E, Kataoka M, Harada S, Sekine M, Matsumoto T, Kurokawa K: Regression of parathyroid hyperplasia by caicitriol pulse therapy in patients on long term dialysis. N Engl J Med 1990;323(6):421-422.
19. Hvoda T, Ono K, Koumi T, Ueda M, Miyaga-wa I, Kodani K, Doi S, lshibashi M, Morita T: Can oral U.SfOHhDj pulse therapy reduce parathyroid hyperplasia? Nephron 1991;59: 171-172.
20. Kleeman CR, Massry SE, Caboum JW: The clinical physiology of calcium homeostasis, parathyroid hormone and calcitonin. Calcif Med 1971:114:16-21.
21. Reiss E, Canterbury JM, Bercovitz MA. Kaplan EL: The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970:49:2146-2149.
22. Rechel H: Medical management of renal hyperparathyroidism pulse treatment with vit D metabolites or not? Nephrol Dial Transplant 1994;9:1368-1370.
23. Lind L, Wengle B, Wide L, Wrege U, Liunghall S: Suppression of serum parathyroid hormone levels by intravenous alphaealcidol in uremic patients on maintenance haemodialysis. Nephron 1988:48:269-299.
24. 1.25dihy-droxy vitamin D: A role of increased sensitivity to calcium. J Clin Invest 1989:83:1349-1355.
25. 2 vitamin D,. Nephron 1991:58:288-294.
26. 2; Dj pulse therapy. Nephron 1989;51: 130-131.
27. Garrick R, Kumar U, Fallon M, Dicarlo E: The efficacy of intravenous and oral caicitriol in the treatment of renal osteodystrophy (abstract). J Am Soc Nephrol 1991;2:610.
28. Gonzalez E, Bander S, Thielan B, Martin KJ: Comparison of intravenous and pulse oral caicitriol for suppression of PTH in patients on hemodialysis (abstract). J Am Soc Nephrol 1991:2:636.
29. 1.25vitamin D therapy on bone disease in patients on chronic dialysis (abstract). J Am Soc Nephrol 1993:4:695.
30. Coburn JW, Norris KC: Diagnosis of aluminum related bone disease and treatment of aluminum toxicity with deferoxamine seminar. Nephrol 1986:6(suppl 1): 12-21.
31. Klaus G, Mehls O, Hinderer J, Ritz E: Intermittent oral caicitriol safe and effective in renal secondary’ hyperparathyroidism? Lancet 1991: 337:800-801.
32. Vande Merwc Mil, Rodger RS, Grant AC, et al: Low calcium dialysate and high dose oral caicitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients. Nephrol Dial Transplant 1990:5:874-877.
33. Seidal A, Herrmann P, Klaus G, Mehls O, Schmidt-Gavk H, Ritz E: Kinetics of plasma iPTH (1-84) after high dose of caicitriol in uremic patients. Clin Nephrol 1993:39:210-213.